American Heart Journal

Article	Citations
Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial	97
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14	97
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile	91
Prediction of In-Hospital Mortality Among Heart Failure Patients: An Automated Machine Learning Analysis of Mimic-III Database	75
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, rando	74
Temporal trends in infection-related hospitalizations among patients with heart failure: A Danish nationwide study from 1997 to 2017	69
Table of Contents	63
Information for Readers	62
Rationale and design of a pragmatic trial aimed at improving treatment of hyperlipidemia in outpatients with very high risk atherosclerotic cardiovascular disease: A pragmatic trial of messaging to pr	52
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	50
Statin-associated muscle symptoms in the VITamin D and OmegA-3 TriaL (VITAL)	50
A cross-stakeholder approach to improving out-of-hospital cardiac arrest survival	49
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	44
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	43
Association between racial residential segregation and Black-White disparities in cardiovascular disease mortality	39
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study	37
Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity	37
Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study	37
Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery di	36
Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy	35
Design of a multi-institutional neurocognitive discovery study in adult congenital heart disease (MINDS-ACHD)	34
The trial to assess chelation therapy 2 (TACT2): Rationale and design	34
Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: A cluster randomized controlled trial for hypertension management in primary care	33
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale	31
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	29

The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	29
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	29
Prognostic value of coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the multi-eth	27
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	27
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	26
Cardiologist perceptions on automated alerts and messages to improve heart failure care	25
Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock	25
Bleeding avoidance strategies and percutaneous coronary intervention outcomes: A 10-year observation from a Japanese Multicenter Registry	24
Effect of patient factors, center, and era on Fontan timing: An observational study using the Pediatric Health Information Systems Database	24
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	24
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	24
Integrating Cost into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction (POCKET-COST-HF): A Trial Providing Out-of-Pocket Costs for Heart Failure Medications during Clinical Enco	24
Changes in coverage, access, and health status among adults with cardiovascular disease after medicaid work requirements	23
Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART study	22
The challenge of sustainability: Long-term results from the Fifty-Fifty peer group-based intervention in cardiovascular risk factors	22
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	22
Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience	22
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial	21
Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms	20
In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging	20
Cardiogenic shock complicating non-ST-segment elevation myocardial infarction: An 18-year study	20
Determinants and prognostic value of albuminuria in adult patients with congenital heart disease	19
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction—1-year follow-up results of the COMPARE CRUSH trial	19
Virtual AppLication-supported Environment To INcrease Exercise (VALENTINE) during cardiac rehabilitation study: Rationale and design	19
Prevalence and clinical correlates and characteristics of “Super Fontan”	19
Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design	19
Is the affordable care act medicaid expansion associated with receipt of heart failure guideline-directed medical therapy by race and ethnicity?	19
Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study	19
Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination	19
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	18
Editorial Board	18
Table of Contents	18
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction	18
Information for Readers	18
Table of Contents	17
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	17
Table of Contents	17
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	17
Table of Contents	17
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	17
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	17
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	17
Investigating the Micrornas as Key Regulator in Diabetic Cardiomyopathy	17
A novel robotic radiation shielding device for electrophysiologic procedures: A prospective study	16
Table of Contents	16
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	16
The effects of pregnancy in subjects with repaired tetralogy of Fallot	16
Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes	16
The pathophysiology of patent foramen ovale and its related complications	16
Table of Contents	16

Longitudinal Study of New Diabetes Cases at Seven Years in a Risk-Sample of Peruvian Subjects with Elevated 1-Hour Ogtt	16
Cardiovascular disease in Filipino American men and women: A 2023 update	15
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	15
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) – Diabetes: rationale and design	15
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease	15
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	15
Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale	14
ASSESSMENT OF ARTERIAL RIGIDITY IN DIABETIC PATIENTS ATTENDED IN A CARDIOLOGY SERVICE	14
High Glucose Variability Increases Mortality Risk in Patients with COVID-19	14
Diabetes-related Foot and Lower Limb Complications and Foot Self-Care Practices in Khartoum, Sudan: A Cross-sectional Study	14
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	14
Independence of clinical events committees: A consensus statement from clinical research organizations	14
The Phenomenon of Metformin in COVID-19 Pandemic Among Polish Patients with Type 2 Diabetes Mellitus	14
RELATIONSHIP BETWEEN ADIPONECTIN AND MYOCARDIAL INFARCTION AMONG DIABETIC PATIENTS	14
Table of Contents	14
Editorial Board	14
Feautures of perioperative period of high-risk patients with coronary artery disease and type 2 Diabetes Mellitus.	14
The bleeding risk treatment paradox at the physician and hospital level: Implications for reducing bleeding in patients undergoing percutaneous coronary intervention	14
Statin and Icosapent Ethyl Use and Lipid Control in US Adults with Diabetes According to DM Risk Groups, Sex and Ethnicity in the NIH Precision Medicine Initiative All of Us Study	14
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	14
Editorial Board	13
Editorial Board	13
Hypertension, microvascular obstruction and infarct size in patients with STEMI undergoing PCI: Pooled analysis from 7 cardiac magnetic resonance imaging studies	13
Information for Readers	13
Response to letter to the editor: “Ambulatory management of cardiac amyloidosis”	13
Impact of targeted pulmonary arterial hypertension therapy in patients with combined post- and precapillary pulmonary hypertension	13
Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial	13
Information for Readers	13
Information for Readers	13
The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement	13
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	12
Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease	12
Response to letters-to-the-editor for publication: “Defect-free care trends in the Paul Coverdell National Acute Stroke Program (PCNASP), 2008-2018. American Heart Journal. 2021;232:177-184. doi:10.10	12
Patients hospitalized for Acute Decompensated Heart Failure with Diabetes Mellitus affected by Non-Alcoholic Fatty Liver Disease have Greater Risk of Mortality and Worse Clinical Outcomes	12
Information for Readers	12
Table of Contents	12
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	12
Table of Contents	12
Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement	12
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	11
Editorial Board	11
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	11
Peripheral atherosclerosis in acute coronary syndrome patients with plaque rupture vs plaque erosion: A prospective coronary optical coherence tomography and peripheral ultrasound study	11
An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI	11
The gut microbiota and coronary artery calcification in Japanese men	11
Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients	11
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study	11
Diabetes and the Risk of Heart Failure Among More Than 60,000 Acute Myocardial Infarction Survivors: A Systematic Review and Meta-Analysis	11
Patients hospitalized for Acute Coronary Syndrome with Diabetes Mellitus affected by Non-Alcoholic Fatty Liver Disease have Greater Risk of Mortality and Worse Clinical Outcomes	11
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	11
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	10
Trial outcome definitions require more attention	10
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy	10
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	10
Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study	10
Editorial Board	10
Table of Contents	10
Association Between the Occurrence of Stroke and Overall Mortality	10
Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	10
Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy	10
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomize	10
Simplifying the ISCHEMIA trial algorithm for clinical practice: Identifying left main coronary artery disease using coronary artery calcium scans	10
Side Effect Synergism Between Metformin and GLP-1 Receptor Agonists	10
Impact of a Cardiometabolic Clinic in Addressing Residual Cardiovascular Risk	10
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial	10
Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: Impact of lesions with acute and chronic coronary	10
Pre-operative atrial fibrillation and early right ventricular failure after left ventricular assist device implantation: a systematic review and meta-analysis	10
Preexisting frailty and outcomes in older patients with acute myocardial infarction	10
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	10
Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison	10
Incident stroke in individuals with peripartum cardiomyopathy	9
Comparison of downsizing strategy (HANGZHOU Solution) and standard annulus sizing strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and	9
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives	9
Diagnostic Potential of miRNA-15a-5p for the Early Detection of Myocardial Infarction	9
Supermarket/hypermarket opportunistic screening for atrial fibrillation (SHOPS-AF) using sensors embedded in the handles of supermarket trolleys: A feasibility study	9
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study	9
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	9
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	9
Harmonization of the definition of sudden cardiac death in longitudinal cohorts of the European Sudden Cardiac Arrest network – towards Prevention, Education, and New Effective Treatments (ESCAPE-NET)	9
Ambulatory management of cardiac amyloidosis	9

Right atrial dysfunction is associated with atrial arrhythmias in adults with repaired tetralogy of fallot	9
Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: Insights from an international cohort of 23,489 patients with acute coronary syndrome	9
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	9
Triglyceride-glucose Index (TyG) is Positively Associated with Nonalcoholic Fatty Liver Disease	9
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	9
Risk markers of incident atrial fibrillation in patients with coronary heart disease	9
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	9
Pregnancy care experiences for adults with congenital heart disease in the United States	9
Physician responses to apple watch-detected irregular rhythm alerts	9
Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol	9
Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study	9
Safety and efficacy of exercise training in children and adolescents with congenital heart disease: A systematic review and descriptive analysis	9
Use of artificial intelligence‐guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE‐echo trial	9
Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial	8
Computed tomography follow-up after elective proximal aortic surgery: Less is more?	8
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study	8
Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trial	8
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights	8
Seeking patient-centered trial outcomes: The case for days alive out of hospital	8
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	8
Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation	8
A global perspective of racial differences and outcomes in patients presenting with acute heart failure	8
Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial	8
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction	8
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	8
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	8
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	7
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	7
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	7
The left atrial appendage exclusion for prophylactic stroke reduction (leaaps) trial: rationale and design	7
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary	7
Overview of the FDA's Circulatory System Devices Panel virtual meeting on the TransMedics Organ Care System (OCS) Heart – portable extracorporeal heart perfusion and monitoring system	7
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	7
Table of Contents	7
Racial and Ethnical Disparities in Dietary Intakes Among Adults with Diagnosed Diabetes: National Health and Nutrition Examination Survey 2011-2020	7
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	7
Table of Contents	7
The protocol of enhanced recovery after cardiac surgery in adult patients: A stepped wedge cluster randomized trial	7
Information for Readers	7
LANDMARK trial: Update in study protocol	7
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	7
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs: design and rationale of the BASELINE trial	7
Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the Symplicity Spyral Renal Denervation System	7
Table of Contents	7
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	7
Table of Contents	7
Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trial	7
Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial	7
Can currently available data on takotsubo syndrome therapies guide us to manage future cases?	7
Feasibility of double-blinded, placebo-controlled interventional study for assessing catheter ablation efficacy in persistent atrial fibrillation: Insights from the ORBITA AF feasibility study	7
Five‐year outcomes with self‐expanding versus balloon‐expandable TAVI in patients with left ventricular systolic dysfunction	7
Association between nitric oxide synthase 3 genetic variant and acute kidney injury following pediatric cardiac surgery	7
Design, rationale, and characterization of the Mobile health based OccuPational cardiovascular risk intErventioN study (mHealth-OPEN Study)	7
Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial	7
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance	7
Post Covid-19 Upturn in Acute MI Related Mortality Trends in Young to Middle Aged Type-2 Diabetics: Observations from CDC Wonder	7
Editorial Board	6
Implementation of a practice plan for the outpatient cardiac evaluation of children after acute SARS-CoV-2 infection and a report of outcomes	6
Potential Cyp3a4-Mediated Drug-Drug Interactions with Ritonavir-Containing Medications in U.S. Patients with Diabetes or Cardiovascular Diseases: An Analysis of Nhanes Data	6
Coagulation and cognitive function - science behind the scenes	6
Finerenone and Cardiorenal Outcomes by History of Cardiovascular Disease in Patients with Type 2 Diabetes: Fidelity Analyses	6
Nigella sativa for the management of hyperglycaemia and dyslipidemia	6
Association of readmission penalty amount with subsequent 30-day risk standardized readmission and mortality rates among patients hospitalized with heart failure: An analysis of get with the guideline	6
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease–2	6
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and prese	6
Editorial Board	6
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial	6
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction	6
To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational Studies	6
Selenium Metabolism and Systemic Inflammation in Hypertensive Patients with Nonalcoholic Fatty Liver Disease	6
Table of Contents	6
Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines – Atrial Fibrillation (GWTG-AFIB) registry	6
Electronic alerts to initiate anticoagulation dialogue in patients with atrial fibrillation	6
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial	6
Lifting the veil off treatment effect heterogeneity	6
Red blood cell transfusion threshold and mortality in cardiac intensive care unit patients	6
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial	6
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups	6
Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry	6
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	6
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	6
Association between economic and arrhythmic burden of paroxysmal atrial fibrillation in patients with cardiac implanted electronic devices	6
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale	6
A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial	6
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	6
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	6
Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction	6
Features of the Trajectories of Glycated Hemoglobin in Patients with CHD and DM 2	5
Table of Contents	5
Exploring the Obesity Paradox: Outcomes in Cardiac Arrest Patients with Obesity	5
Unfavorable social determinants of health and mortality risk by cardiovascular disease status: Findings from a National Study of United States Adults	5
5 Year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft Surgery in Patients with Diabetes and Multivessel Disease	5
The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design	5
MAFLD and Cardiovascular Disease Risk Assessment in the Primary Care Setting	5